Brian Grow - Feb 15, 2022 Form 4 Insider Report for Organogenesis Holdings Inc. (ORGO)

Role: Chief Commercial Officer
Signature: /s/ William R. Kolb, Attorney-in-Fact
Stock symbol: ORGO
Transactions as of: Feb 15, 2022
Transactions value $: -$6,216
Form type: 4
Date filed: 2/17/2022, 05:57 PM
Next filing: Apr 5, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ORGO	Class A Common Stock	Award	$0	+45.1K	+101.28%	$0.00	89.7K	Feb 15, 2022	Direct	F1
transaction	ORGO	Class A Common Stock	Tax liability	-$6.22K	-799	-0.89%	$7.78	88.9K	Feb 16, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ORGO	Stock Option (Right to Buy)	Award	$0	+107K		$0.00	107K	Feb 15, 2022	Class A Common Stock	107K	$8.03	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2022.
F2	The option becomes exercisable in equal annual installments over four years beginning February 15, 2022.